Into clinical practice:

Meeting the challenges of Gram-negative infection management

4 October 2023
ONLINE CONFERENCE

You can now view the recordings from this conference on demand here.

This conference is RCPath CPD accredited.

Programme

0845

Opening remarks

Dr Louise Sweeney, Consultant Medical Microbiologist, Manchester University NHS Foundation Trust - View Bio

SESSION ONE: What's new?

Chair: Dr Louise Sweeney, Consultant Medical Microbiologist, Manchester University NHS Foundation Trust - View Bio

0850

Delinkage 1 year on

Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK and immediate Past President, BSAC - View Bio

0910

SMASH study

Dr Ioannis Baltas, ST3 Infectious Diseases & Microbiology, University College London Hospitals NHS Foundation Trust & NIHR Academic Clinical Fellow in Infectious Diseases & Microbiology - View Bio

0930

Q&A (10 minutes)

SESSION TWO: Antimicrobial Susceptibility Testing (AST) - the present and the future

Chair: Dr Mandy Wootton, Consultant Scientist/Operational Manager, Specialist Antimicrobial Chemotherapy Unit (SACU), Public Health Wales - View Bio

0945

EUCAST update

Professor Alasdair MacGowan, Consultant in Infection, North Bristol NHS Trust & Professor of Antimicrobial Therapeutics, University of Bristol - View Bio

1005

Interpreting AST for paediatric patients

Dr Malte Kohns, University Children’s Hospital Basel

1015

BSAC strategy and support for UK clinicians

Dr Nick Brown, Consultant Medical Microbiologist, Cambridge University Hospitals NHS Trust - View Bio

1035

Q&A (20 minutes)

SESSION THREE: Clinical Cases

Chair: Dr Sanjay Patel, Consultant in Paediatric Infectious Diseases and Immunology, Southampton Children’s Hospital - View Bio

1105

Unravelling the Phylogenetic History of Klebsiella pneumoniae Strains from Portugal: Insights on National And International Dissemination events

Dr Rita Elias, PhD student, iMed.ULisboa - Instituto de Investigação do Medicamento Faculdade de Farmácia da Universidade de Lisboa, Portugal - View Bio

1120

Prevalence and antibiotic profile of carbapenem resistant gram negative pathogens isolated from ventilator associated pneumonia patients in tertiary hospitals in Pakistan

Dr Zeb Hussain, PhD Student, University of Karachi - View Bio

1135

In vitro efficacy of novel therapeutic options for infections caused by carbapenemase-producing organisms

Dr Saied Ali, Microbiology Specialist Registrar, St Vincent's University Hospital - View Bio

1150

Rational Antibiotic Escalation In Gram Negative Infections Applied to Specific Patient Groups

Dr Philip Williams, UKHSA & UHBW NHS Trust

SESSION FOUR

Supported by: Pfizer

1210

Real-world experience in the management of carbapenem resistance

Dr Anita Verma, Consultant Microbiologist, Kings College Hospital NHS Trust

SESSION FIVE

Supported by: This presentation is for UK healthcare professionals only and contains promotional content and is sponsored by A. Menarini Farmaceutica Internazionale SRL. September 2023 | PP-AI-UK-0570

1250

Potential options for treating cipro-resistant Pseudomonas aeruginosa

Dr Jennifer Yung, Respiratory SpR, Manchester University Foundation Trust - View Bio

SESSION SIX: Review & analysis - imported and emerging infections

Chair: Mrs Frances Garraghan, Specialist Antimicrobial Stewardship Pharmacist, Manchester University NHS Foundation Trust - View Bio

1320

Harnessing population-wide microbiology data for AMR surveillance and innovation

Dr Nick Daneman, Professor of Medicine, University of Toronto and Infection Prevention Physician, Public Health Ontario - View Bio

Dr Kevin Brown, Infectious disease epidemiologist & health services researcher, Public Health Ontario & University of Toronto - View Bio

1340

Multidrug-resistant Gram-negative bacterial infections in war victims

Major Scott Pallett, ST5 Microbiology & Infectious Diseases Defence Medical Services, Frimley Park Hospital - View Bio

1400

Improving infection management - the MSF Mini-Lab in a LMIC setting

Professor Dimitri Van der Linden, Paediatric Infectious Diseases Consultant, Cliniques universitaires Saint-Luc (UCLouvain) - View Bio

Marjan Peeters, Médecins Sans Frontières (MSF) - View Bio

1420

Q&A (15 minutes)

SESSION SEVEN: Debate - Should all neonates in whom treatment with aminoglycoside antibiotics is being considered, have genetic testing for the A1555G mutation?

Chair: Dr Sanjay Patel, Consultant in Paediatric Infectious Diseases and Immunology, Southampton Children’s Hospital - View Bio

1440

Scene setting

Dr Sanjay Patel, Consultant in Paediatric Infectious Diseases and Immunology, Southampton Children’s Hospital - View Bio

1445

Pros

Professor Bill Newman, Chair of Translational Genomic Medicine & Consultant in Clinical Genetics, University of Manchester & Manchester University NHS Foundation Trust. - View Bio

1455

Cons

Mr Stephen Hughes, Consultant Antimicrobial Pharmacist, Chelsea and Westminster Hospital NHS Foundation Trust - View Bio

1505

Discussion

SESSION EIGHT: Invited lecture

Chair: Dr Louise Sweeney, Consultant Medical Microbiologist, Manchester University NHS Foundation Trust - View Bio

1540

Why is the clinical treatment of Stenotrophomonas maltophilia still so challenging?

Dr Maria Mojica, Senior Instructor, Department of Molecular Biology & Microbiology, Case Western Reserve University, USA - View Bio

1600

Q&A (10 minutes)

SESSION NINE: The real world impact of data - controlling an outbreak

Chair: Dr Louise Sweeney, Consultant Medical Microbiologist, Manchester University NHS Foundation Trust - View Bio

1615

Detection and control of water-borne infection in augmented care units – are we doing enough?

Dr Jessica Martin, Clinical Microbiologist & Medical Lead for IPC and AMR, Leeds Teaching Hospitals Trust - View Bio

1655

To Screen or Not to Screen for Gram-negatives in Infection Control

Professor Mark Wilcox, Leeds Teaching Hospitals NHS Trust - View Bio

1715

Q&A

1730

Closing remarks

Dr Louise Sweeney, Consultant Medical Microbiologist, Manchester University NHS Foundation Trust - View Bio

1735

Into clinical practice:

Meeting the challenges of Gram-negative infection management

4 October 2023ONLINE CONFERENCE

Programme

4 October 2023
ONLINE CONFERENCE